Nitta K - Search Results

1

New Insights into Cystic Kidney Diseases.

Mochizuki T, Makabe S, Aoyama Y, Kataoka H, Nitta K. Mochizuki T, et al. Among authors: nitta k. Contrib Nephrol. 2018;195:31-41. doi: 10.1159/000486932. Epub 2018 May 7. Contrib Nephrol. 2018. PMID: 29734148 Review.

2

Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.

Kataoka H, Ohara M, Honda K, Mochizuki T, Nitta K. Kataoka H, et al. Among authors: nitta k. Nephrol Dial Transplant. 2011 Dec;26(12):3937-43. doi: 10.1093/ndt/gfr139. Epub 2011 Mar 22. Nephrol Dial Transplant. 2011. PMID: 21427079

3

A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1.

Ochi A, Takei T, Ichikawa A, Kojima C, Moriyama T, Itabashi M, Mochizuki T, Taniguchi A, Nitta K. Ochi A, et al. Among authors: nitta k. Clin Exp Nephrol. 2012 Apr;16(2):316-9. doi: 10.1007/s10157-011-0557-3. Epub 2011 Nov 3. Clin Exp Nephrol. 2012. PMID: 22045201

4

Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters.

Kataoka H, Ohara M, Shibui K, Sato M, Suzuki T, Amemiya N, Watanabe Y, Honda K, Mochizuki T, Nitta K. Kataoka H, et al. Among authors: nitta k. Clin Exp Nephrol. 2012 Oct;16(5):706-12. doi: 10.1007/s10157-012-0613-7. Epub 2012 Feb 17. Clin Exp Nephrol. 2012. PMID: 22350469

5

Risk factors for vitamin D deficiency in patients with chronic kidney disease.

Echida Y, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Echida Y, et al. Among authors: nitta k. Intern Med. 2012;51(8):845-50. doi: 10.2169/internalmedicine.51.6897. Epub 2012 Apr 15. Intern Med. 2012. PMID: 22504237 Free article.

6

Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan.

Saito T, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Saito T, et al. Among authors: nitta k. Heart Vessels. 2013 May;28(3):323-9. doi: 10.1007/s00380-012-0254-5. Epub 2012 Apr 21. Heart Vessels. 2013. PMID: 22526382

7

Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.

8

Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.

Mochizuki T, Tsuchiya K, Nitta K. Mochizuki T, et al. Among authors: nitta k. Clin Exp Nephrol. 2013 Jun;17(3):317-26. doi: 10.1007/s10157-012-0741-0. Epub 2012 Nov 29. Clin Exp Nephrol. 2013. PMID: 23192769 Review.

9

Serum uric acid levels and long-term outcomes in chronic kidney disease.

Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K. Miyaoka T, et al. Among authors: nitta k. Heart Vessels. 2014 Jul;29(4):504-12. doi: 10.1007/s00380-013-0396-0. Epub 2013 Aug 9. Heart Vessels. 2014. PMID: 23929090

10

Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.

Kawanishi K, Sawada A, Ochi A, Moriyama T, Mitobe M, Mochizuki T, Honda K, Oda H, Nishikawa T, Nitta K. Kawanishi K, et al. Among authors: nitta k. Case Rep Nephrol Urol. 2013 Nov 28;3(2):128-35. doi: 10.1159/000356849. eCollection 2013 Jul. Case Rep Nephrol Urol. 2013. PMID: 24570682 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,500 results

Search Page